The mRNA Revolution: Beyond COVID to Cancer, Flu and Herpes Vaccines

Welcome to Biotech Blueprint. If you want to subscribe to a free weekly biotech/pharma newsletter, you can do so here: https://www.biotechblueprint.com/embed In this special episode, I teamed up again with Hartaj from the Biotech Capital Compass for part one of our mRNA therapeutics mini series. We covered the foundational science behind how RNA became medicine, the decades of bioengineering breakthroughs that made COVID vaccines possible, and what’s coming next in the infectious disease space. From Moderna’s ambitious pipeline targeting everything from flu-COVID combo shots to latent viruses like CMV and EBV, to Moderna’s and BioNTech’s custom cancer vaccines, we mapped out what's actually coming in the next few years.